Showing results (91-100 of 6,005) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|August 14, 2015
CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast CancerJingyu Xiang, Michelle A Hurchla, Francesca Fontana, et al.
Molecular Cancer Therapeutics|August 14, 2015
Redesigning a Monospecific Anti-FGFR3 Antibody to Add Selectivity for FGFR2 and Expand Antitumor ActivityYiyuan Yin, Stevan Djakovic, Scot Marsters, et al.
Molecular Cancer Therapeutics|August 15, 2015
HSP90 Inhibitor-SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to TumorsDavid A Proia, Donald L Smith, Junyi Zhang, et al.
Molecular Cancer Therapeutics|October 18, 2013
ATP citrate lyase mediates resistance of colorectal cancer cells to SN38Yunfei Zhou, Lakshmi Reddy Bollu, Federico Tozzi, et al.
Molecular Cancer Therapeutics|November 15, 2013
Protein-tyrosine phosphatase H1 increases breast cancer sensitivity to antiestrogens by dephosphorylating estrogen receptor at Tyr537Padmanaban S Suresh, Shao Ma, Antimo Migliaccio, et al.
Molecular Cancer Therapeutics|November 15, 2013
Superior antitumor activity of a novel bispecific antibody cotargeting human epidermal growth factor receptor 2 and type I insulin-like growth factor receptorChao Chen, Yanyu Zhang, Yu Zhang, et al.
Molecular Cancer Therapeutics|October 17, 2013
Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinomaHelei Hou, Hefen Sun, Ping Lu, et al.
Molecular Cancer Therapeutics|October 17, 2013
Cytoreductive chemotherapy improves the biodistribution of antibodies directed against tumor necrosis in murine solid tumor modelsJulie K Jang, Leslie A Khawli, Ryan Park, et al.
Molecular Cancer Therapeutics|October 17, 2013
Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growthMarc A Becker, Thahir Farzan, Sean C Harrington, et al.
Molecular Cancer Therapeutics|October 22, 2013
Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma modelOliver Surriga, Vinagolu K Rajasekhar, Grazia Ambrosini, et al.
Pageof 601